|
|
--- |
|
|
tags: |
|
|
- sentence-transformers |
|
|
- sentence-similarity |
|
|
- feature-extraction |
|
|
- dense |
|
|
- generated_from_trainer |
|
|
- dataset_size:27120 |
|
|
- loss:ContrastiveLoss |
|
|
base_model: cambridgeltl/SapBERT-from-PubMedBERT-fulltext |
|
|
widget: |
|
|
- source_sentence: 'anencephaly [SEP] Sequential observations of exencephaly and subsequent |
|
|
morphological changes by mouse exo utero development system: analysis of t' |
|
|
sentences: |
|
|
- Hemostatic Disorders [SEP] Pathological processes involving the integrity of blood |
|
|
circulation. Hemostasis depends on the integrity of BLOOD VESSELS, blood |
|
|
- Pentylenetetrazole [SEP] A pharmaceutical agent that displays activity as a central |
|
|
nervous system and respiratory stimulant. It is considered a non-comp |
|
|
- Epilepsy [SEP] A disorder characterized by recurrent episodes of paroxysmal brain |
|
|
dysfunction due to a sudden, disorderly, and excessive neuron |
|
|
- source_sentence: nifedipine [SEP] The effect of nifedipine on renal function in |
|
|
liver transplant recipients who were receiving tacrolimus was evaluated between |
|
|
Ja |
|
|
sentences: |
|
|
- 'Nifedipine [SEP] A potent vasodilator agent with calcium antagonistic action. |
|
|
It is a useful anti-anginal agent that also lowers blood pressure. |
|
|
|
|
|
' |
|
|
- Hypotension [SEP] Abnormally low BLOOD PRESSURE that can result in inadequate |
|
|
blood flow to the brain and other vital organs. Common symptom is DI |
|
|
- Granulomatosis with Polyangiitis [SEP] A multisystemic disease of a complex genetic |
|
|
background. It is characterized by inflammation of the blood vessels (VASCULITIS) |
|
|
l |
|
|
- source_sentence: toxicity [SEP] Effects of calcium channel blockers on bupivacaine-induced |
|
|
toxicity. |
|
|
sentences: |
|
|
- 'Methamphetamine [SEP] A central nervous system stimulant and sympathomimetic |
|
|
with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is ' |
|
|
- Dizocilpine Maleate [SEP] A potent noncompetitive antagonist of the NMDA receptor |
|
|
(RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The dr |
|
|
- Hallucinations [SEP] Subjectively experienced sensations in the absence of an |
|
|
appropriate stimulus, but which are regarded by the individual as real. |
|
|
- source_sentence: Ca [SEP] Interactive effects of variations in [Na]o and [Ca]o on |
|
|
rat atrial spontaneous frequency. |
|
|
sentences: |
|
|
- Brain Edema [SEP] Increased intracellular or extracellular fluid in brain tissue. |
|
|
Cytotoxic brain edema (swelling due to increased intracellular f |
|
|
- "Capsaicin [SEP] An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS.\n\ |
|
|
\ " |
|
|
- "Thrombocytopenia [SEP] A subnormal level of BLOOD PLATELETS.\n " |
|
|
- source_sentence: acromegaly [SEP] This article reports the changes in gallbladder |
|
|
function examined by ultrasonography in 20 Chinese patients with active acromega |
|
|
sentences: |
|
|
- "Indocyanine Green [SEP] A tricarbocyanine dye that is used diagnostically in\ |
|
|
\ liver function tests and to determine blood volume and cardiac output.\n " |
|
|
- Nitroglycerin [SEP] A volatile vasodilator which relieves ANGINA PECTORIS by stimulating |
|
|
GUANYLATE CYCLASE and lowering cytosolic calcium. It is als |
|
|
- Nausea [SEP] An unpleasant sensation in the stomach usually accompanied by the |
|
|
urge to vomit. Common causes are early pregnancy, sea and moti |
|
|
pipeline_tag: sentence-similarity |
|
|
library_name: sentence-transformers |
|
|
--- |
|
|
|
|
|
# SentenceTransformer based on cambridgeltl/SapBERT-from-PubMedBERT-fulltext |
|
|
|
|
|
This is a [sentence-transformers](https://www.SBERT.net) model finetuned from [cambridgeltl/SapBERT-from-PubMedBERT-fulltext](https://huggingface.co/cambridgeltl/SapBERT-from-PubMedBERT-fulltext). It maps sentences & paragraphs to a 768-dimensional dense vector space and can be used for semantic textual similarity, semantic search, paraphrase mining, text classification, clustering, and more. |
|
|
|
|
|
## Model Details |
|
|
|
|
|
### Model Description |
|
|
- **Model Type:** Sentence Transformer |
|
|
- **Base model:** [cambridgeltl/SapBERT-from-PubMedBERT-fulltext](https://huggingface.co/cambridgeltl/SapBERT-from-PubMedBERT-fulltext) <!-- at revision 090663c3ae57bf35ffe4d0d468a2a88d03051a4d --> |
|
|
- **Maximum Sequence Length:** 512 tokens |
|
|
- **Output Dimensionality:** 768 dimensions |
|
|
- **Similarity Function:** Cosine Similarity |
|
|
<!-- - **Training Dataset:** Unknown --> |
|
|
<!-- - **Language:** Unknown --> |
|
|
<!-- - **License:** Unknown --> |
|
|
|
|
|
### Model Sources |
|
|
|
|
|
- **Documentation:** [Sentence Transformers Documentation](https://sbert.net) |
|
|
- **Repository:** [Sentence Transformers on GitHub](https://github.com/huggingface/sentence-transformers) |
|
|
- **Hugging Face:** [Sentence Transformers on Hugging Face](https://huggingface.co/models?library=sentence-transformers) |
|
|
|
|
|
### Full Model Architecture |
|
|
|
|
|
``` |
|
|
SentenceTransformer( |
|
|
(0): Transformer({'max_seq_length': 512, 'do_lower_case': False, 'architecture': 'BertModel'}) |
|
|
(1): Pooling({'word_embedding_dimension': 768, 'pooling_mode_cls_token': True, 'pooling_mode_mean_tokens': False, 'pooling_mode_max_tokens': False, 'pooling_mode_mean_sqrt_len_tokens': False, 'pooling_mode_weightedmean_tokens': False, 'pooling_mode_lasttoken': False, 'include_prompt': True}) |
|
|
) |
|
|
``` |
|
|
|
|
|
## Usage |
|
|
|
|
|
### Direct Usage (Sentence Transformers) |
|
|
|
|
|
First install the Sentence Transformers library: |
|
|
|
|
|
```bash |
|
|
pip install -U sentence-transformers |
|
|
``` |
|
|
|
|
|
Then you can load this model and run inference. |
|
|
```python |
|
|
from sentence_transformers import SentenceTransformer |
|
|
|
|
|
# Download from the 🤗 Hub |
|
|
model = SentenceTransformer("Stevenf232/context_fine-tuned-SapBERT") |
|
|
# Run inference |
|
|
sentences = [ |
|
|
'acromegaly [SEP] This article reports the changes in gallbladder function examined by ultrasonography in 20 Chinese patients with active acromega', |
|
|
'Nitroglycerin [SEP] A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is als', |
|
|
'Indocyanine Green [SEP] A tricarbocyanine dye that is used diagnostically in liver function tests and to determine blood volume and cardiac output.\n ', |
|
|
] |
|
|
embeddings = model.encode(sentences) |
|
|
print(embeddings.shape) |
|
|
# [3, 768] |
|
|
|
|
|
# Get the similarity scores for the embeddings |
|
|
similarities = model.similarity(embeddings, embeddings) |
|
|
print(similarities) |
|
|
# tensor([[1.0000, 0.2218, 0.3974], |
|
|
# [0.2218, 1.0000, 0.5304], |
|
|
# [0.3974, 0.5304, 1.0000]]) |
|
|
``` |
|
|
|
|
|
<!-- |
|
|
### Direct Usage (Transformers) |
|
|
|
|
|
<details><summary>Click to see the direct usage in Transformers</summary> |
|
|
|
|
|
</details> |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
### Downstream Usage (Sentence Transformers) |
|
|
|
|
|
You can finetune this model on your own dataset. |
|
|
|
|
|
<details><summary>Click to expand</summary> |
|
|
|
|
|
</details> |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
### Out-of-Scope Use |
|
|
|
|
|
*List how the model may foreseeably be misused and address what users ought not to do with the model.* |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
## Bias, Risks and Limitations |
|
|
|
|
|
*What are the known or foreseeable issues stemming from this model? You could also flag here known failure cases or weaknesses of the model.* |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
### Recommendations |
|
|
|
|
|
*What are recommendations with respect to the foreseeable issues? For example, filtering explicit content.* |
|
|
--> |
|
|
|
|
|
## Training Details |
|
|
|
|
|
### Training Dataset |
|
|
|
|
|
#### Unnamed Dataset |
|
|
|
|
|
* Size: 27,120 training samples |
|
|
* Columns: <code>sentence_0</code>, <code>sentence_1</code>, and <code>label</code> |
|
|
* Approximate statistics based on the first 1000 samples: |
|
|
| | sentence_0 | sentence_1 | label | |
|
|
|:--------|:----------------------------------------------------------------------------------|:----------------------------------------------------------------------------------|:---------------------------------------------------------------| |
|
|
| type | string | string | float | |
|
|
| details | <ul><li>min: 9 tokens</li><li>mean: 27.48 tokens</li><li>max: 63 tokens</li></ul> | <ul><li>min: 4 tokens</li><li>mean: 24.74 tokens</li><li>max: 43 tokens</li></ul> | <ul><li>min: 0.0</li><li>mean: 0.21</li><li>max: 1.0</li></ul> | |
|
|
* Samples: |
|
|
| sentence_0 | sentence_1 | label | |
|
|
|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:-----------------| |
|
|
| <code>toxic to the central nervous system [SEP] Treatment for scabies is usually initiated by general practitioners; most consider lindane (gamma benzene hexachloride) the trea</code> | <code>Thyrotoxicosis [SEP] A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous </code> | <code>0.0</code> | |
|
|
| <code>cancer [SEP] Doxorubicin is an effective anticancer chemotherapeutic agent known to cause acute and chronic cardiomyopathy. To develop a more</code> | <code>Nystagmus, Pathologic [SEP] Involuntary movements of the eye that are divided into two types, jerk and pendular. Jerk nystagmus has a slow phase in one dire</code> | <code>0.0</code> | |
|
|
| <code>doxorubicin [SEP] Doxorubicin is an effective anticancer chemotherapeutic agent known to cause acute and chronic cardiomyopathy. To develop a more</code> | <code>Cisplatin [SEP] An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and inter</code> | <code>0.0</code> | |
|
|
* Loss: [<code>ContrastiveLoss</code>](https://sbert.net/docs/package_reference/sentence_transformer/losses.html#contrastiveloss) with these parameters: |
|
|
```json |
|
|
{ |
|
|
"distance_metric": "SiameseDistanceMetric.COSINE_DISTANCE", |
|
|
"margin": 0.5, |
|
|
"size_average": true |
|
|
} |
|
|
``` |
|
|
|
|
|
### Training Hyperparameters |
|
|
#### Non-Default Hyperparameters |
|
|
|
|
|
- `per_device_train_batch_size`: 16 |
|
|
- `per_device_eval_batch_size`: 16 |
|
|
- `fp16`: True |
|
|
- `multi_dataset_batch_sampler`: round_robin |
|
|
|
|
|
#### All Hyperparameters |
|
|
<details><summary>Click to expand</summary> |
|
|
|
|
|
- `do_predict`: False |
|
|
- `eval_strategy`: no |
|
|
- `prediction_loss_only`: True |
|
|
- `per_device_train_batch_size`: 16 |
|
|
- `per_device_eval_batch_size`: 16 |
|
|
- `gradient_accumulation_steps`: 1 |
|
|
- `eval_accumulation_steps`: None |
|
|
- `torch_empty_cache_steps`: None |
|
|
- `learning_rate`: 5e-05 |
|
|
- `weight_decay`: 0.0 |
|
|
- `adam_beta1`: 0.9 |
|
|
- `adam_beta2`: 0.999 |
|
|
- `adam_epsilon`: 1e-08 |
|
|
- `max_grad_norm`: 1 |
|
|
- `num_train_epochs`: 3 |
|
|
- `max_steps`: -1 |
|
|
- `lr_scheduler_type`: linear |
|
|
- `lr_scheduler_kwargs`: None |
|
|
- `warmup_ratio`: None |
|
|
- `warmup_steps`: 0 |
|
|
- `log_level`: passive |
|
|
- `log_level_replica`: warning |
|
|
- `log_on_each_node`: True |
|
|
- `logging_nan_inf_filter`: True |
|
|
- `enable_jit_checkpoint`: False |
|
|
- `save_on_each_node`: False |
|
|
- `save_only_model`: False |
|
|
- `restore_callback_states_from_checkpoint`: False |
|
|
- `use_cpu`: False |
|
|
- `seed`: 42 |
|
|
- `data_seed`: None |
|
|
- `bf16`: False |
|
|
- `fp16`: True |
|
|
- `bf16_full_eval`: False |
|
|
- `fp16_full_eval`: False |
|
|
- `tf32`: None |
|
|
- `local_rank`: -1 |
|
|
- `ddp_backend`: None |
|
|
- `debug`: [] |
|
|
- `dataloader_drop_last`: False |
|
|
- `dataloader_num_workers`: 0 |
|
|
- `dataloader_prefetch_factor`: None |
|
|
- `disable_tqdm`: False |
|
|
- `remove_unused_columns`: True |
|
|
- `label_names`: None |
|
|
- `load_best_model_at_end`: False |
|
|
- `ignore_data_skip`: False |
|
|
- `fsdp`: [] |
|
|
- `fsdp_config`: {'min_num_params': 0, 'xla': False, 'xla_fsdp_v2': False, 'xla_fsdp_grad_ckpt': False} |
|
|
- `accelerator_config`: {'split_batches': False, 'dispatch_batches': None, 'even_batches': True, 'use_seedable_sampler': True, 'non_blocking': False, 'gradient_accumulation_kwargs': None} |
|
|
- `parallelism_config`: None |
|
|
- `deepspeed`: None |
|
|
- `label_smoothing_factor`: 0.0 |
|
|
- `optim`: adamw_torch_fused |
|
|
- `optim_args`: None |
|
|
- `group_by_length`: False |
|
|
- `length_column_name`: length |
|
|
- `project`: huggingface |
|
|
- `trackio_space_id`: trackio |
|
|
- `ddp_find_unused_parameters`: None |
|
|
- `ddp_bucket_cap_mb`: None |
|
|
- `ddp_broadcast_buffers`: False |
|
|
- `dataloader_pin_memory`: True |
|
|
- `dataloader_persistent_workers`: False |
|
|
- `skip_memory_metrics`: True |
|
|
- `push_to_hub`: False |
|
|
- `resume_from_checkpoint`: None |
|
|
- `hub_model_id`: None |
|
|
- `hub_strategy`: every_save |
|
|
- `hub_private_repo`: None |
|
|
- `hub_always_push`: False |
|
|
- `hub_revision`: None |
|
|
- `gradient_checkpointing`: False |
|
|
- `gradient_checkpointing_kwargs`: None |
|
|
- `include_for_metrics`: [] |
|
|
- `eval_do_concat_batches`: True |
|
|
- `auto_find_batch_size`: False |
|
|
- `full_determinism`: False |
|
|
- `ddp_timeout`: 1800 |
|
|
- `torch_compile`: False |
|
|
- `torch_compile_backend`: None |
|
|
- `torch_compile_mode`: None |
|
|
- `include_num_input_tokens_seen`: no |
|
|
- `neftune_noise_alpha`: None |
|
|
- `optim_target_modules`: None |
|
|
- `batch_eval_metrics`: False |
|
|
- `eval_on_start`: False |
|
|
- `use_liger_kernel`: False |
|
|
- `liger_kernel_config`: None |
|
|
- `eval_use_gather_object`: False |
|
|
- `average_tokens_across_devices`: True |
|
|
- `use_cache`: False |
|
|
- `prompts`: None |
|
|
- `batch_sampler`: batch_sampler |
|
|
- `multi_dataset_batch_sampler`: round_robin |
|
|
- `router_mapping`: {} |
|
|
- `learning_rate_mapping`: {} |
|
|
|
|
|
</details> |
|
|
|
|
|
### Training Logs |
|
|
| Epoch | Step | Training Loss | |
|
|
|:------:|:----:|:-------------:| |
|
|
| 0.2950 | 500 | 0.0106 | |
|
|
| 0.5900 | 1000 | 0.0065 | |
|
|
| 0.8850 | 1500 | 0.0058 | |
|
|
| 1.1799 | 2000 | 0.0045 | |
|
|
| 1.4749 | 2500 | 0.0038 | |
|
|
| 1.7699 | 3000 | 0.0036 | |
|
|
| 2.0649 | 3500 | 0.0036 | |
|
|
| 2.3599 | 4000 | 0.0027 | |
|
|
| 2.6549 | 4500 | 0.0027 | |
|
|
| 2.9499 | 5000 | 0.0027 | |
|
|
|
|
|
|
|
|
### Framework Versions |
|
|
- Python: 3.12.12 |
|
|
- Sentence Transformers: 5.2.3 |
|
|
- Transformers: 5.0.0 |
|
|
- PyTorch: 2.9.0+cu128 |
|
|
- Accelerate: 1.12.0 |
|
|
- Datasets: 4.0.0 |
|
|
- Tokenizers: 0.22.2 |
|
|
|
|
|
## Citation |
|
|
|
|
|
### BibTeX |
|
|
|
|
|
#### Sentence Transformers |
|
|
```bibtex |
|
|
@inproceedings{reimers-2019-sentence-bert, |
|
|
title = "Sentence-BERT: Sentence Embeddings using Siamese BERT-Networks", |
|
|
author = "Reimers, Nils and Gurevych, Iryna", |
|
|
booktitle = "Proceedings of the 2019 Conference on Empirical Methods in Natural Language Processing", |
|
|
month = "11", |
|
|
year = "2019", |
|
|
publisher = "Association for Computational Linguistics", |
|
|
url = "https://arxiv.org/abs/1908.10084", |
|
|
} |
|
|
``` |
|
|
|
|
|
#### ContrastiveLoss |
|
|
```bibtex |
|
|
@inproceedings{hadsell2006dimensionality, |
|
|
author={Hadsell, R. and Chopra, S. and LeCun, Y.}, |
|
|
booktitle={2006 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (CVPR'06)}, |
|
|
title={Dimensionality Reduction by Learning an Invariant Mapping}, |
|
|
year={2006}, |
|
|
volume={2}, |
|
|
number={}, |
|
|
pages={1735-1742}, |
|
|
doi={10.1109/CVPR.2006.100} |
|
|
} |
|
|
``` |
|
|
|
|
|
<!-- |
|
|
## Glossary |
|
|
|
|
|
*Clearly define terms in order to be accessible across audiences.* |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
## Model Card Authors |
|
|
|
|
|
*Lists the people who create the model card, providing recognition and accountability for the detailed work that goes into its construction.* |
|
|
--> |
|
|
|
|
|
<!-- |
|
|
## Model Card Contact |
|
|
|
|
|
*Provides a way for people who have updates to the Model Card, suggestions, or questions, to contact the Model Card authors.* |
|
|
--> |